S100A8 and neoplasm: In line with our results, Drews-Elger et al. [14] demonstrated that recruitment of S100A8+ myeloid cells in xenograft models of breast cancer enhance tumor progression independent of their suppressive activity on T cells using immunosuppressed mouse models.